SynerFuse, Inc., wani kamfani mai zaman kansa, kamfanin na'urar na'urar likitanci na asibiti ya mayar da hankali kan ci gaba da wani sabon ra'ayi na maganin neuromodulation don maganin ciwon baya na kullum, a yau ya sanar da cewa US Patent & Trademark Office (USPTO) ya ba da lambar yabo ta Amurka. 11,247,046 mai suna Hanyoyi da Tsarin don Dasa Tsarin Neuromodulation a Wurin Buɗe Jiyya na Ƙashin Ƙarya. Bayar da haƙƙin mallaka na '046 zai ƙara zuwa kamfani na haɓaka haƙƙin mallaka na duniya wanda a halin yanzu ya haɗa da haƙƙin mallaka na 63 da aikace-aikacen patent da aka buga.
Sabuwar takardar shaidar '046 da aka ba da ita ta ƙunshi sanyawa kai tsaye na na'urar neuromodulation a kan tushen ganglion na dorsal, wani makasudin jijiya da aka sani don ba da jin zafi ga haƙƙin mallaka lokacin da aka yi maganin neuromodulation. Wannan lambar yabo ta cika abin da aka bayar na US 10,675,458 a baya, mai suna Hanyoyi da Tsarin Tsarin Tsarin Tsarin Neuromodulation da Tsarin Kayyade Kaya a Wurin Jiyya na Kashin Kashin Nama, wanda ke rufe hadewar gyaran kashin baya da neuromodulation don jiyya guda ɗaya na rauni na kashin baya ciwon baya na kullum.
Justin Zenanko, co-kafa da kuma babban jami'in zartarwa na SynerFuse ya ce, "Wannan lamban kira yana ƙara wa girma a duniya patent fayil don tallafa wa SynerFuse ci gaban wani labari hadedde far ra'ayin domin lura da ciwo mai tsanani da kuma kara complements da kuma kare mu ci gaba da zuba jari a yunƙurin haɓaka aikin asibiti da samfur."
"Wasu matakai a cikin tafiyarmu sun ɗan bambanta," in ji Co-Founder da Babban Jami'in Kimiyya Dr. Greg Molnar. "Wannan takaddun shaida na musamman yana kare SynerFuse mara lafiyar kula da ciwo na narcotic don aikace-aikacen gaba a cikin yawan masu haƙuri."
SynerFuse Mataimakin Shugaban Kasuwancin Fasaha Chris Frank, JD; Lauyan Jeffrey R. Stone na kamfanin lauyoyin kasuwanci Barnes & Thornburg LLP; kuma Molnar sun jagoranci yunkurin mallakar fasaha na kamfanin.
